Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Pharmacists purchase semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) or tirzepatide (the active ingredient in Zepbound) and mix their own medications
A laboratory document is listed only when it has been published for this product and the relevant batch
expect a thorough assessment
The headline results at 80 weeks were: 12 mg dose: average weight loss of 28.3% (approximately 70.3 lbs / 31.9 kg) 9 mg dose: average weight loss of 25.9% (approximately 64.4 lbs / 29.2 kg) 4 mg dose: average weight loss of 19.0% (approximately 47.2 lbs / 21.4 kg) Placebo: average weight loss of just 2.2% Perhaps most striking was the proportion of patients hitting bariatric-surgery-level outcomes: at the highest dose, 45.3% of participants lost 30% or more of their body weight , and 65.3% reduced their BMI to below 30 kg/m meaning they were no longer classified as living with obesity by the end of the trial
US$ 25.72
US$ 27.46
US$ 20.23
US$ 20.73
US$ 21.84
US$ 29.28
